Clinical Trials Directory

Trials / Completed

CompletedNCT00833001

Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse

A Prospective, Multi-center Study to Evaluate the Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse

Status
Completed
Phase
Study type
Observational
Enrollment
126 (actual)
Sponsor
Ethicon, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the clinical performance of the PROLIFT system with a new lighter-weight mesh in repair of vaginal prolapse.

Detailed description

Vaginal prolapse (a feeling of bulge in the vagina) may cause some distressing symptoms such as loss of control of the bowel or bladder, and may also cause problems with women's sex life. There are a number of different surgical procedures which are used to repair prolapse. Sometimes a mesh is placed in the pelvis to support the weakened tissues. There is a lot of research going on to find the most suitable type of mesh to repair vaginal prolapse. The GYNECARE PROLIFT + M\* Pelvic Floor Repair system is similar to a mesh already used for this procedure called ULTRAPRO\*, but is lighter in weight. Currently, ULTRAPRO\* is only approved for use in hernia repair and is not licensed for gynecological procedures. This study will be the first clinical investigation of this mesh in vaginal prolapse.

Conditions

Interventions

TypeNameDescription
DEVICEGYNECARE PROLIFT+M* Pelvic Floor Repair SystemPre-shaped mesh implants made of GYNECARE GYNEMESH M composite mesh, comprised of absorbable polyglecaprone 25 monofilament fiber and nonabsorbable polypropylene monofilament fiber

Timeline

Start date
2008-04-01
Primary completion
2009-11-01
Completion
2011-12-01
First posted
2009-01-30
Last updated
2014-05-06

Locations

8 sites across 4 countries: Belgium, France, Germany, Netherlands

Source: ClinicalTrials.gov record NCT00833001. Inclusion in this directory is not an endorsement.